$54.83
+2.41 (+4.60%)
Analyst Consensus
Buy
35
Analysts
Very High
Coverage
Price Target
Analyst Price Target
+102.6% upside
Low Target
$83.97
Average Target
$111.08
High Target
$162.31
Current Price
$54.83
Current
$54.83
$54.83
Target
$111.08
$111.08
$83.97
$111.08 avg
$162.31
Scenario Analysis
Bear Case
$83.97
53.1%
Low target
Base Case
$111.08
+102.6%
Avg target
Bull Case
$162.31
+196.0%
High target
Risk/Reward
3.7x
Highly favorable
Price in Context
52-Week High
$78.48
-30.1% from high
52-Week Low
$33.50
+63.7% from low
50-Day SMA
$54.19
+1.2% vs SMA
200-Day SMA
$54.12
+1.3% vs SMA
RSI (14)
52.8
Neutral
Target vs 52W High
$111.08
+41.5% vs high
Next Earnings Report
May 11, 2026
1d
tomorrow
EPS Est: $-1.25
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Buy | 39 | 72% | $257.58 | +27.8% |
| AMGN | Hold | 43 | 49% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 26 | 96% | $143.40 | +41.5% |